| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Vaxcyte, Inc.'s insiders have reduced their positions by a net 45,442 shares worth roughly $3.7M.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 429.9K | $26.14M | - | |
| COO | 145.4K | $8.84M | - | |
| CFO | 95.3K | $5.80M | - | |
| Other | 68.1K | $4.14M | - | |
| Other | 52.6K | $3.20M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 6, 2025 | Mikhail Eydelman67 | SVP, Gen Counsel & Corp Sec | Sale+OE10b5-1 | 5,000 | $85.58 | $427,922.80 | -15.1% | -62.2% | -47.8% | |
| Jan 2, 2025 | Jim Wassil53 | Chief Operating Officer | Sale+OE10b5-1 | 8,000 | $83.66 | $669,266.91 | -3.7% | -59.6% | -44.2% | |
| Dec 18, 2024 | Andrew Guggenhime46 | President and CFO | Sale+OE10b5-1 | 8,000 | $88.78 | $710,248.58 | -6.8% | -12.9% | -49.0% | |
| Dec 9, 2024 | Grant Pickering50 | Chief Executive Officer | Sell10b5-1 | 2,366 | $92.25 | $218,252.88 | -1.7% | -25.2% | -51.4% | |
| Dec 5, 2024 | Mikhail Eydelman67 | SVP, Gen Counsel & Corp Sec | Sale+OE10b5-1 | 5,000 | $91.49 | $457,433.92 | -14.8% | -17.9% | -48.4% | |
| Dec 2, 2024 | Grant Pickering50 | Chief Executive Officer | Sell10b5-1 | 15,000 | $92.45 | $1,386,794.41 | -3.2% | -21.3% | -51.2% | |
| Dec 2, 2024 | Jim Wassil53 | Chief Operating Officer | Sale+OE10b5-1 | 8,000 | $92.49 | $739,884.53 | -3.7% | -21.3% | -51.2% | |
| Nov 18, 2024 | Andrew Guggenhime46 | President and CFO | Sale+OE10b5-1 | 8,000 | $85.81 | $686,517.55 | -6.8% | -4.6% | -42.7% | |
| Nov 7, 2024 | Grant Pickering50 | Chief Executive Officer | Sale+OE10b5-1 | 2,366 | $103.89 | $245,796.25 | -1.7% | -13.0% | -59.4% | |
| Nov 5, 2024 | Mikhail Eydelman67 | SVP, Gen Counsel & Corp Sec | Sale+OE10b5-1 | 5,000 | $106.36 | $531,803.36 | -14.9% | -21.2% | -62.5% |